---
schema_version: "secwatch.filing_event.v1"
accession: "0001799191-23-000037"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T18:41:35.123595+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "low"
source: SEC EDGAR
---

# Oncology Institute releases Q2 2023 results and 2023 guidance; no specific figures in filing text

## Summary
- Company furnished slide presentation with Q2 and H1 2023 financial results on August 10, 2023.
- Management provided updated business guidance for the year ending December 31, 2023.
- No revenue, EPS, or other numeric details are extractable from the available filing exhibits.
- Tickers: TOI (common stock) and TOIIW (warrants).

## SEC filing metadata
- accession: 0001799191-23-000037
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/0001799191-23-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/toi-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001799191-23-000037
- JSON: https://secwatch.observer/filing/0001799191-23-000037.json
- Plain text: https://secwatch.observer/filing/0001799191-23-000037.txt

## Key facts
- Earnings Releases
  Oncology Institute, Inc. reported financial results for the three months ended June 30, 2023.
  - Period: the three months ended June 30, 2023
  - Result: reported results
  source text: On August 10, 2023, The Oncology Institute, Inc. (the "Company") issued a slide presentation which includes the Company's financial results for the three months and six months ended June 30, 2023 and certain other financial information.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/0001799191-23-000037-index.htm
- Earnings Releases
  Oncology Institute, Inc. reported financial results for the six months ended June 30, 2023.
  - Period: the six months ended June 30, 2023
  - Result: reported results
  source text: On August 10, 2023, The Oncology Institute, Inc. (the "Company") issued a slide presentation which includes the Company's financial results for the three months and six months ended June 30, 2023 and certain other financial information.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/0001799191-23-000037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.